Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
结核分枝杆菌先天免疫逃避的机制
基本信息
- 批准号:10390674
- 负责人:
- 金额:$ 66.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAllelesAttenuatedAutophagocytosisAutophagolysosomeBacillusBacteriaBacterial InfectionsCause of DeathCellsDataDoseGenerationsGoalsGrowthHumanImmuneImmune EvasionImmunityImpairmentInfectionInfection ControlInnate Immune ResponseInnovative TherapyKnockout MiceLipidsLungLysosomesMediator of activation proteinMicrobeMitochondriaModelingMusMycobacterium tuberculosisMyeloid CellsNADPNADPH OxidaseOxidasesPathway interactionsPersonsPhagocytosisPhagolysosomePhagosomesPhospholipase DPlayProductionPropertyProtein Export PathwayProteinsReactive Oxygen SpeciesRoleSiteSystemTestingTetracyclinesTuberculosisTuberculosis VaccinesVaccinesVirulenceVirulence FactorsWorkacute infectionantimicrobialblocking factorcell typechronic infectionconditional knockoutimprovedin vivoinnate immune functioninnate immune mechanismsinnovationinsightmacrophagemutantmycobacterialneutrophilnovel strategiespathogenpreventrecruittraffickingtuberculosis treatment
项目摘要
SUMMARY
The goal of this project is to understand how two virulence factors from Mycobacterium tuberculosis (Mtb), CpsA
and phthiocerol dimycocerosate (PDIM), impair immunity by undermining both classical and non-classical
autophagy. Mtb is the causative agent of tuberculosis (TB), the leading cause of death worldwide from a bacterial
infection. The main cellular niche for Mtb is macrophages and neutrophils, the very immune cells that are meant
to clear infection. How Mtb survives the innate immune response to establish infection is not well understood. In
the previous project period, we discovered that an exported protein, CpsA, is critically important for Mtb virulence.
We showed that CpsA inhibits phagosomal recruitment of the NADPH oxidase. The NADPH oxidase makes
reactive oxygen species (ROS), an important mediator of the innate immune response. In addition to its direct
antimicrobial activity, ROS is required for a lysosomal trafficking pathway called LC3-associated phagocytosis
(LAP), a non-classical form of autophagy. Thus, by inhibiting ROS, CpsA also inhibits LAP. We showed both in
macrophages and mice that CpsA protects Mtb from the NADPH oxidase and LAP. Interestingly, CpsA physically
interacts NDP52 and TAX1BP1, autophagy adaptors that function in a form of classical autophagy (xenophagy),
suggesting that CpsA may also impair xenophagy. Moreover, we found that the Mtb virulence lipid, PDIM, also
inhibits the NADPH oxidase. Previous studies proposed an array of roles for PDIM and showed that it protects
Mtb from a poorly defined innate killing mechanism. Our data suggest that an unappreciated virulence property
of PDIM is blocking the NADPH oxidase and LAP. Thus, we hypothesize that CpsA inhibits xenophagy and
works in concert with PDIM to inhibit the NADPH oxidase and LAP. Further, we propose that the infectious dose
of Mtb depends upon its ability to evade these innate defenses in myeloid cells that are recruited to the lungs
during initial infection. Here, we will define how CpsA inhibits the NADPH oxidase and investigate whether it also
impairs xenophagy by blocking NDP52 and TAX1BP1 function. We will determine whether PDIM also impairs
recruitment of the NADPH oxidase to mycobacterial phagosomes and evaluate the contribution that PDIM plays
towards subverting the NADPH oxidase and LAP in vivo. To determine whether CpsA promotes the
establishment of infection, we will use an ultra-low dose infection model in mice. Using conditional knockout
(cKO) mice, we will determine in which cells CpsA functions to inhibit the NADPH oxidase and LAP during acute
and chronic infection. Our findings will provide mechanistic insight into how two key virulence factors in Mtb
collaborate to undermine immunity. Our studies will reveal a cell type-specific virulence strategy of the bacilli,
delineate the cell types that participate in LAP in vivo, and define host-pathogen interactions that govern the
establishment of infection. Our studies will provide detailed mechanistic insight into the immune evasion
strategies of one of the world's most formidable pathogens. By elucidating the mechanism of action of two crucial
virulence factors in Mtb, we will advance innovative approaches to prevent and treat TB.
总结
本项目的目的是了解结核分枝杆菌(Mtb)的两种毒力因子CpsA
和Phthiocerol dimycerosate(PDIM),通过破坏经典和非经典免疫力
自噬结核分枝杆菌是结核病(TB)的病原体,结核病是全世界由细菌引起的死亡的主要原因。
感染结核分枝杆菌的主要细胞生态位是巨噬细胞和嗜中性粒细胞,
清除感染结核分枝杆菌如何在先天免疫反应中存活以建立感染尚不清楚。在
在前一个项目期间,我们发现输出蛋白CpsA对Mtb毒力至关重要。
我们发现CpsA抑制吞噬体募集NADPH氧化酶。NADPH氧化酶使
活性氧(ROS)是先天性免疫反应的重要介质。除了直接
抗微生物活性,ROS是称为LC 3相关吞噬作用的溶酶体运输途径所必需的
(LAP),一种非经典的自噬形式。因此,通过抑制ROS,CpsA也抑制ROS。我们展示了
巨噬细胞和小鼠中,CpsA保护Mtb免受NADPH氧化酶和NADPH氧化酶的影响。有趣的是,CpsA在物理上
NDP 52和TAX 1BP 1相互作用,自噬衔接子以经典的自噬(xenophagy)形式起作用,
这表明CpsA也可能损害嗜异性。此外,我们发现Mtb毒力脂质PDIM也
抑制NADPH氧化酶。以前的研究提出了PDIM的一系列作用,并表明它可以保护
结核分枝杆菌从一个定义不清的先天杀伤机制。我们的数据表明,一种未被重视的毒力特性
PDIM的作用是阻断NADPH氧化酶和NADPH氧化酶。因此,我们假设CpsA抑制了异嗜性,
与PDIM协同作用以抑制NADPH氧化酶和NADPH。此外,我们建议,
结核分枝杆菌的感染依赖于它逃避这些在骨髓细胞中被招募到肺部的先天防御的能力
在最初的感染。在这里,我们将定义CpsA如何抑制NADPH氧化酶,并调查它是否也
通过阻断NDP 52和TAX 1BP 1功能来削弱异嗜性。我们将确定PDIM是否也会损害
招募NADPH氧化酶的分枝杆菌吞噬体和评估的贡献,PDIM发挥
在体内破坏NADPH氧化酶和NADPH氧化酶。为了确定CpsA是否促进了
感染的建立,我们将采用超低剂量感染小鼠模型。使用条件敲除
(cKO)在小鼠中,我们将确定CpsA在哪些细胞中发挥作用,在急性期抑制NADPH氧化酶和LAP
慢性感染。我们的研究结果将为结核分枝杆菌的两个关键毒力因子
合作破坏豁免权我们的研究将揭示杆菌的细胞类型特异性毒力策略,
描述参与体内细胞增殖的细胞类型,并定义控制细胞增殖的宿主-病原体相互作用。
建立感染。我们的研究将为免疫逃避提供详细的机制见解,
世界上最可怕的病原体之一的战略。通过阐明两个关键的作用机制
我们将推进预防和治疗结核病的创新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JENNIFER A PHILIPS其他文献
JENNIFER A PHILIPS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JENNIFER A PHILIPS', 18)}}的其他基金
Cholesterol oxidation products in TB pathogenesis and as biomarkers of disease
结核病发病机制中的胆固醇氧化产物及其作为疾病的生物标志物
- 批准号:
10216045 - 财政年份:2021
- 资助金额:
$ 66.07万 - 项目类别:
Cholesterol oxidation products in TB pathogenesis and as biomarkers of disease
结核病发病机制中的胆固醇氧化产物及其作为疾病的生物标志物
- 批准号:
10343850 - 财政年份:2021
- 资助金额:
$ 66.07万 - 项目类别:
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
结核分枝杆菌先天免疫逃避的机制
- 批准号:
10531921 - 财政年份:2017
- 资助金额:
$ 66.07万 - 项目类别:
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
结核分枝杆菌先天免疫逃避的机制
- 批准号:
10078851 - 财政年份:2017
- 资助金额:
$ 66.07万 - 项目类别:
THE ROLE OF ESCRT IN MACROPHAGE RESISTANCE TO MYCOBACTERIA
ESCRT 在巨噬细胞抵抗分枝杆菌中的作用
- 批准号:
9125720 - 财政年份:2015
- 资助金额:
$ 66.07万 - 项目类别:
THE ROLE OF UBIQUILINS IN INNATE IMMUNITY TO TUBERCULOSIS
泛素在结核病先天免疫中的作用
- 批准号:
8636559 - 财政年份:2014
- 资助金额:
$ 66.07万 - 项目类别:
THE ROLE OF UBIQUILINS IN INNATE IMMUNITY TO TUBERCULOSIS
泛素在结核病先天免疫中的作用
- 批准号:
9062959 - 财政年份:2014
- 资助金额:
$ 66.07万 - 项目类别:
The Role of ESCRT in Macrophage Resistance to Mycobacteria
ESRT 在巨噬细胞对分枝杆菌耐药中的作用
- 批准号:
8670599 - 财政年份:2013
- 资助金额:
$ 66.07万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 66.07万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 66.07万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 66.07万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 66.07万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 66.07万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 66.07万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 66.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 66.07万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 66.07万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 66.07万 - 项目类别:














{{item.name}}会员




